Table 1.
Molecular characteristics of seven bladder cancer cell lines.
| Tissue Type | Cell Line | Mutation | Amplification | Deletion | Fusion |
|---|---|---|---|---|---|
| Urinary bladder | 5637 | TP53 | ERBB3 | N/A | N/A |
| RB1 | |||||
| ERBB2 | |||||
| Urinary bladder | J82 | TP53 | N/A | PTEN | N/A |
| PIK3CA | |||||
| FGFR3 | |||||
| RB1 | |||||
| MTOR | |||||
| RET | |||||
| Urinary bladder | SW-780 | FGFR3 | N/A | CDKN2A | N/A |
| CDKN2B | |||||
| Urinary bladder | RT4 | RhoA | FGFR3 | HRAS | N/A |
| TSC1 | AKT2 | CDKN2A | |||
| CDKN2B | |||||
| MTOR | |||||
| Urinary bladder | T24 | TP53 | N/A | N/A | N/A |
| HRAS | |||||
| Urinary bladder | UMUC-3 | KRAS | N/A | CDKN2A | N/A |
| ERBB3 | CDKN2B | ||||
| PTEN | |||||
| VEGFR | |||||
| Urinary bladder | 235J-BV | PIK3CA | N/A | N/A | N/A |
| ERBB4 |